Arrivederci, GINA
By Alex Philippidis,
Genetic Engineering & Biotechnology News
| 02. 04. 2013
Yaniv Erlich, Ph.D., and his research team at the Whitehead Institute hoped to start a conversation when they published their study in Science showing that all they needed to identify nearly 50 individuals who had submitted personal genetic material for genomic studies was just a computer, an Internet connection, and publicly accessible online resources.
That conversation has raised many of the right questions when it comes to privacy of genetic information. Answers, however, remain elusive despite the study and other recent developments in addressing the issue of genetic privacy, including publication last fall of a report by the U.S. Presidential Commission for the Study of Bioethical Issues.
The commission’s report, Privacy and Progress in Whole Genome Sequencing, stressed that individual interests in privacy must be respected and secured to realize the promise of whole genome sequencing in advancing clinical care and the greater public good.
One key recommendation calls for Washington to join states in hammering out “a consistent floor of protections” ensuring security for whole-genome sequence data, rather than the limited approach of the Genetic Information Nondiscrimination Act...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Elizabeth Chuck, NBC News | 07.09.2024
A Netflix docuseries has put a spotlight on the unregulated world of sperm donation, particularly the lack of stopgap measures that might prevent donors who have been banned by one country from simply going elsewhere to donate more.
Released earlier...
By Amanda Becker and Shefali Luthra, The 19th | 07.08.2024
Image by Duke University Archives from Flickr
Republicans have adopted a slate of policy positions ahead of next week’s convention that does not call for a federal legislative abortion ban, but opens the door to establishing fetal personhood.
The Republican...